Published in Exp Eye Res on October 01, 2004
PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression. AAPS J (2009) 1.03
Stealth dendrimers for antiarrhythmic quinidine delivery. J Mater Sci Mater Med (2007) 0.94
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proc Natl Acad Sci U S A (2010) 0.90
Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina. Invest Ophthalmol Vis Sci (2015) 0.84
Liposomes and nanotechnology in drug development: focus on ocular targets. Int J Nanomedicine (2013) 0.83
Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers. J Biol Eng (2012) 0.78
Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics. Indian J Pharm Sci (2010) 0.76
Nanoparticle-motivated gene delivery for ophthalmic application. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.76
Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomedicine (2015) 0.75
Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci (2003) 2.18
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
A new principle for tight junction modulation based on occludin peptides. Mol Pharmacol (2003) 1.88
Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc Natl Acad Sci U S A (2007) 1.82
Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci (2003) 1.49
Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue. Genet Vaccines Ther (2004) 1.47
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorg Med Chem (2006) 1.23
Modern subunit vaccines: development, components, and research opportunities. ChemMedChem (2013) 1.22
Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys. Mol Ther (2005) 1.19
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. Atherosclerosis (2007) 1.16
Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results. Doc Ophthalmol (2003) 1.14
Self-adjuvanting lipopeptide vaccines. Curr Med Chem (2008) 1.10
Adenovirus and adeno-associated virus vectors. DNA Cell Biol (2002) 1.10
Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother (2013) 1.10
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol Heart Circ Physiol (2003) 1.06
Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Deliv (2006) 1.01
Cellular uptake of densely packed polymer coatings on gold nanoparticles. ACS Nano (2010) 0.98
Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. J Med Chem (2012) 0.98
Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano (2012) 0.97
VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res (2005) 0.96
Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci (2003) 0.95
Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology (2012) 0.94
Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. Angew Chem Int Ed Engl (2010) 0.94
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates. J Med Chem (2007) 0.94
Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates. Bioorg Med Chem (2008) 0.92
Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res (2012) 0.92
Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Curr Drug Deliv (2005) 0.91
Inhibition of corneal neovascularization by recombinant adenovirus mediated antisense VEGF RNA. Exp Eye Res (2002) 0.90
Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine. J Control Release (2009) 0.90
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis (2006) 0.89
Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol (2005) 0.89
Functional and structural evaluation after AAV.RPE65 gene transfer in the canine model of Leber's congenital amaurosis. Adv Exp Med Biol (2003) 0.89
Long-term effect of therapeutic laser photocoagulation on gene expression in the eye. FASEB J (2005) 0.89
Chemical methods for peptide and protein production. Molecules (2013) 0.87
Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations. J Gene Med (2003) 0.87
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun (2002) 0.87
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS One (2012) 0.87
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships. Front Immunol (2013) 0.86
Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. J Med Chem (2012) 0.85
Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect Immun (2003) 0.85
In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorg Med Chem (2008) 0.85
Quantitative model demonstrating that recombinant adeno-associated virus and green fluorescent protein are non-toxic to the rat retina. Clin Experiment Ophthalmol (2003) 0.85
Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers. Biomacromolecules (2011) 0.84
Detailed NMR, including 1,1-ADEQUATE, and anticancer studies of compounds from the echinoderm Colobometra perspinosa. Mar Drugs (2009) 0.84
Toll-like receptor agonists: a patent review (2011 - 2013). Expert Opin Ther Pat (2014) 0.84
Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice. Invest Ophthalmol Vis Sci (2005) 0.84
Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation. Int J Pharm (2005) 0.84
Peptide-based subunit nanovaccines. Curr Drug Deliv (2011) 0.84
Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights. Pharm Res (2014) 0.83
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand. J Med Chem (2012) 0.83
Bastadin 21, a novel isobastarane metabolite from the Great Barrier Reef marine sponge Ianthella quadrangulata. J Nat Prod (2002) 0.83
Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components. J Med Chem (2010) 0.83
Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery. Methods Mol Biol (2011) 0.83
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. Bioorg Med Chem Lett (2007) 0.83
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. Bioorg Med Chem (2008) 0.83
Preclinical evaluation of a phosphorothioate oligonucleotide in the retina of rhesus monkey. Lab Invest (2002) 0.83
Design, synthesis, and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin. J Med Chem (2004) 0.82
Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy. Diabetes (2003) 0.82
Peptide-based subunit vaccine against hookworm infection. PLoS One (2012) 0.82
Oral vaccine delivery--new strategies and technologies. Curr Drug Deliv (2009) 0.82
Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer. Biomacromolecules (2013) 0.82
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin. Bioorg Med Chem (2005) 0.82
rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector. Invest Ophthalmol Vis Sci (2009) 0.82
Peptide conjugation via CuAAC 'click' chemistry. Molecules (2013) 0.82
Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem (2010) 0.82
Simple synthetic toll-like receptor 2 ligands. Bioorg Med Chem Lett (2011) 0.82
Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2. Vaccine (2009) 0.81
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunol Cell Biol (2002) 0.81
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. J Med Chem (2003) 0.81
Advances in peptide-based human papillomavirus therapeutic vaccines. Curr Top Med Chem (2012) 0.81
A model for a blinding eye disease of the aged. Biogerontology (2002) 0.81
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery. Bioorg Med Chem (2007) 0.81
Biological properties and therapeutic potential of bilirubin. Mini Rev Med Chem (2003) 0.81
Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. Vaccine (2009) 0.81
Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. Eur J Pharm Sci (2002) 0.80
Monoclonal antibodies against 3-deoxy-alpha-D-manno-oct-2-ulosonic acid (Kdo) and D-glycero-alpha-D-talo-oct-2-ulosonic acid (Ko). J Endotoxin Res (2002) 0.80
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine. Nanomedicine (Lond) (2013) 0.80
Modern lipid-, carbohydrate-, and peptide-based delivery systems for peptide, vaccine, and gene products. Med Res Rev (2009) 0.80
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models. Int J Pharm (2006) 0.80
Lipo-endomorphin-1 derivatives with systemic activity against neuropathic pain without producing constipation. PLoS One (2012) 0.80
The microarray: potential applications for ophthalmic research. Mol Vis (2002) 0.80
Oral absorption and in vivo biodistribution of alpha-conotoxin MII and a lipidic analogue. Biochem Biophys Res Commun (2007) 0.80
Liposome-based delivery system for vaccine candidates: constructing an effective formulation. Nanomedicine (Lond) (2012) 0.80
Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation. J Med Chem (2006) 0.80
Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta (2006) 0.80
Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response. Curr Drug Deliv (2010) 0.79
Impurity of recombinant adeno-associated virus type 2 affects the transduction characteristics following subretinal injection in the rat. Vision Res (2004) 0.79
Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage. J Med Chem (2004) 0.79
Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis. Bioorg Med Chem (2010) 0.79
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines. J Med Chem (2007) 0.79
Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res (2006) 0.79
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. J Med Chem (2008) 0.79